JMJD5-RCCD1 Complex Drives Platinum Resistance in Non-Small Cell Lung Cancer
A study in Molecular Biomedicine reveals that the JMJD5-RCCD1 complex promotes platinum resistance in NSCLC by driving FN1-mediated epithelial–mesenchymal transition ...
A study in Molecular Biomedicine reveals that the JMJD5-RCCD1 complex promotes platinum resistance in NSCLC by driving FN1-mediated epithelial–mesenchymal transition ...
A new quantitative systems pharmacology model spanning all three classes of BRAF-mutant lung cancer predicts that MEK-ERK inhibitor combinations can ...
First clinical data from the Phase 1b/2 BNT324-01 trial show that the investigational combination of pumitamig and elfetabart drozuntecan achieved ...
Hidden RNA Molecule Acts as a Built-In Brake on Lung Cancer's Fat-Fueled Growth Scientists in China have identified a long ...
As global efforts to curb tobacco smoking have gradually borne fruit, a perplexing and increasingly significant subset of lung cancer ...
In an exhilarating stride toward understanding lung cancer’s biochemical landscape, researchers have unveiled a complex yet compelling portrait of how ...
In a groundbreaking study published in Cancer Cell, researchers at The University of Texas MD Anderson Cancer Center have unveiled ...
In a groundbreaking study published in the prestigious journal Nature on November 5, 2025, researchers at NYU Langone Health have ...
In a groundbreaking advance in computational oncology, researchers at Graz University of Technology (TU Graz) have developed an extraordinarily detailed ...
In a groundbreaking development at the crossroads of oncology and cardiology, researchers have uncovered novel molecular mechanisms underpinning cardiac cachexia ...
© 2026 Scienmag - Science Magazine
© 2026 Scienmag - Science Magazine